Development stage: Market-ready products, e.g. first sales, accepted prototypes and customer testing, clinical trial data available
Potential sales: Accessible markets > 250 million euros worldwide, growth > 5% p.a.; market and product advantage permit rapid sales growth: industrial scale (>10 million euros) attainable within five years; innovation-driven market with high potential benefit to customers; customer demand already existent.
Potential returns: Cash break-even point within reach, ideally within two to three years
Age of company: Firm founded/ spun off no more than five years ago
Sector: Life sciences/ healthcare
- Medical technology
- Diagnostics
- Biotechnology/ pharmaceuticals (later stage)
- Applied technologies
We do not invest in research or development institutes!
Management: Product- and technology-related positions filled very
well; other core roles filled sufficiently or can be filled quickly if
needed.
Investment needs: No more than 3-5 million euros in the first round
of financing; no more than 6-10 million euros total for all rounds of
financing.